AEterna Zentaris to Announce Outcome of Management's Strategic Review



    QUEBEC CITY, Sept. 27 /CNW Telbec/ - AEterna Zentaris Inc. (TSX: AEZ;
Nasdaq:   AEZS), a global biopharmaceutical company focused on endocrine therapy
and oncology, today announced that it will host a conference call and webcast
on Tuesday, October 2, 2007 at 11:00 a.m. Eastern time regarding the outcome
of management's strategic review of the Company's pipeline and business
operations. Participants may access the live webcast via the Company's website
at www.aeternazentaris.com in the "Investors" section, or by telephone using
the following numbers: 416-644-3414, 514-807-8791 or 800-733-7571.
    A replay of the webcast will also be available on the Company's website
for a period of 30 days.

    About AEterna Zentaris Inc.

    AEterna Zentaris Inc. is global biopharmaceutical company focused on
endocrine therapy and oncology with proven expertise in drug discovery,
development and commercialization.
    News releases and additional information are available at
www.aeternazentaris.com.




For further information:

For further information: Jenene Thomas, Senior Director, Investor
Relations & Corporate Communications, (908) 938-1475,
jenene.thomas@aeternazentaris.com; Paul Burroughs, Media Relations, (418)
652-8525 ext. 406, paul.burroughs@aeternazentaris.com

Organization Profile

Aeterna Zentaris Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890